|
|
.
See Category: Neoplasms
ICD-10 (CM) Code and Descriptor
|
C78.5 |
Secondary malignant neoplasm of large intestine and rectum
|
C785 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 11.58%
|
19.50%
|
20.42%
|
16.08%
|
11.60%
|
6.82%
|
5.14%
|
3.19%
|
2.32%
|
1.79%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C78.5*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
752
|
752
|
|
80053
|
COMPREHEN METABOLIC PANEL |
700
|
700
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
562
|
563
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
536
|
538
|
|
83735
|
ASSAY OF MAGNESIUM |
291
|
294
|
|
96375
|
TX/PRO/DX INJ NEW DRUG ADDON |
237
|
396
|
|
96413
|
CHEMO IV INFUSION 1 HR |
228
|
228
|
|
J1642
|
INJ HEPARIN SODIUM PER 10 U |
219
|
7,911
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
215
|
18,933
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
208
|
2,200
|
|
88341
|
IMHCHEM/IMCYTCHM EA ADD ANTB |
193
|
721
|
|
82378
|
CARCINOEMBRYONIC ANTIGEN |
191
|
191
|
|
J2405
|
ONDANSETRON HCL INJECTION |
189
|
1,387
|
|
74177
|
CT ABD & PELVIS W/CONTRAST |
178
|
178
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
177
|
5,273
|
|
97530
|
THERAPEUTIC ACTIVITIES |
176
|
340
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
170
|
268
|
|
J3010
|
FENTANYL CITRATE INJECTION |
167
|
277
|
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
160
|
182
|
|
80048
|
METABOLIC PANEL TOTAL CA |
157
|
158
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C78.5 related to the following DRG Codes:
374-376
|
